Print this page

Observations placeholder

Cystic fibrosis: evidence for gut inflammation

Identifier

020185

Type of spiritual experience

Background

A link to intestine disease has been provided, as more suggestions for healing are available there

A description of the experience

Int J Biochem Cell Biol. 2014 Jul;52:180-3. doi: 10.1016/j.biocel.2014.02.005. Epub 2014 Feb 15.

Cystic fibrosis: evidence for gut inflammation.

Munck A1.

  • 1Assistance publique-Hôpitaux de Paris, Hôpital Robert Debré, Paediatric Gastroenterology and Respiratory Department, CF Center, Université Paris 7, 75019 Paris, France. Electronic address: anne.munck@rdb.aphp.fr.

Abstract

Cystic fibrosis (CF) gut manifestations are predominantly secondary to cystic fibrosis transmembrane regulator protein (CFTR) dysfunction. The CFTR gene is expressed throughout the intestinal tract. Because the intestine is difficult to assess in humans, there exists a lack of data on the underlying mechanisms of intestinal dysfunction. A more tractable approach involves the use of mouse models of CF, created by gene targeting techniques, to describe the consequences of CFTR dysfunction in the intestinal tissues, including mucus accumulation, disturbed motility, small bowel bacterial overgrowth and inflammation with altered innate immune responses, that are likely to be interrelated. We will focus on the latter. Recently, in people with CF, even in the absence of overt gastrointestinal symptoms, chronic intestinal inflammation and abnormal balance of the microbiota have been evidenced. Because chronic gut inflammation may be a driver for systemic inflammation, the prevention and control of intestinal inflammation represents a promising research strategy.

Copyright © 2014 Elsevier Ltd. All rights reserved.

KEYWORDS:

Cystic fibrosis; Gut; Immune response; Inflammation

PMID:

24548777

The source of the experience

PubMed

Concepts and Symbols used in the text or image

Activities

Observation contributed by: Rosie Rock-Evans